Springworks Invest Information

Companies
SpringWorks Therapeutics Schedules Q2 2024 Earnings Call for August 7 Jul 24, 2024
Pharmaceuticals
SpringWorks Therapeutics Begins Rolling NDA Submission for NF1-PN Treatment Mar 5, 2024
Markets
SpringWorks Therapeutics Announces Presentation at J.P. Morgan Healthcare Conference Dec 21, 2023